trial · primary record
Cetuximab
Metastatic Colorectal Cancer
| Phase | Phase 2 |
|---|---|
| Status | COMPLETED |
| Sponsor | Unknown |
| Enrolment | 47 |
| Primary completion | 2013-05 |
| Primary endpoint | Objective response rate (according to RECIST criteria) |
| Registry ID | NCT01225744 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T13:41:09.879Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT01225744
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.
Same entity, elsewhere in the suite
- Cetuximab · compound